Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01043042 · ClinicalTrials.gov registry record
Identification of Inpatients at Risk for Poor Glycemic Control
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 33,011
- Enrollment target
NCT01043042: Completed study, sponsored by Vanderbilt University Medical Center.
NCT01043042 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 33,011 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01043042 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 33,011 participants
- Enrollment target
Study Summary
Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present at admission that identify patients at greater risk of poor inpatient glycemic control
Interventions
- OTHER No interventions will be used in this study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33,011 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-09 |
What the finished NCT01043042 record still lists
NCT01043042 is an observational study that tracks outcomes without assigning an intervention. Its 33,011 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No interventions will be used in this study is the first listed.
NCT01043042 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01043042 about?
NCT01043042 is a clinical study titled "Identification of Inpatients at Risk for Poor Glycemic Control". Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present ...
What is the current status of trial NCT01043042?
This trial is currently completed. The enrollment target is 33,011 participants. The study started on 2010-01. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01043042?
The interventions under investigation include: No interventions will be used in this study (OTHER).
Who is sponsoring clinical trial NCT01043042?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia